生成式AI重寫全球新藥產業的競爭規則。過去AI多應用於醫療影像判讀、疾病診斷及醫院管理，如今已深入藥物研發最核心環節，從靶點發掘、候選分子設計、藥物篩選、臨床試驗到上市後的精準行銷，幾乎涵蓋整個新藥價值鏈，也讓製藥產業邁入「AI製藥」新時代。
H2O.ai, the sovereign enterprise AI platform for predictive, generative and agentic AI, with built-in observability and ...
Tech Times on MSN
Acer Swift Spin 14 AI opens preorders: Only Snapdragon X2 convertible with bundled stylus
Acer Swift Spin 14 AI preorders are open in the US at $1,499.99, shipping August 16 — the first Snapdragon X2 Elite ...
In this week’s podcast, Cyber Daily’s Daniel Croft and David Hollingworth argue for sovereign Australian AI, catch up with ...
The U.S. Department of Energy is harnessing the artificial intelligence boom in its bid to convert another Cold War-era ...
The new research initiative will examine artificial intelligence's impact on Australia's security, from cyber threats & ...
Software teams are generating code faster than ever with AI, yet many see the bottleneck shifting to delivery speed and code ...
New modelling from MYOB has indicated that adopting AI and automation could unlock significant growth for the nation’s established small and local accounting practices.
メタリアル＜６１８２＞の連結子会社である株式会社ロゼッタは、高精度産業翻訳ＡＩ「Ｔ－４ＯＯ」の『高精度』モードの対応言語を、２０２６年７月２８日付で従来の３６言語から７０言語に拡充する。セルビア語・ウズベク語・ラオ語など・・・。
New conversational builder replaces the blank prompt box with a four-step interview covering purpose, content, style, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results